639 related items for PubMed ID: 11464450
1. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Levine B.
Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
[Abstract] [Full Text] [Related]
2. Perindopril plus nifedipine versus perindopril plus hydrochlorothiazide in mild to severe hypertension: a double-blind multicentre study. The Multicentre Study Group on Treatment Association with Perindopril.
Letellier P, Overlack A, Agnes E, Desche P.
J Hum Hypertens; 1994 Feb; 8(2):145-9. PubMed ID: 8207741
[Abstract] [Full Text] [Related]
3. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.
MacKay JH, Arcuri KE, Goldberg AI, Snapinn SM, Sweet CS.
Arch Intern Med; 1996 Feb 12; 156(3):278-85. PubMed ID: 8572837
[Abstract] [Full Text] [Related]
4. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
Breithaupt-Grögler K, Gerhardt G, Lehmann G, Notter T, Belz GG.
Int J Clin Pharmacol Ther; 1998 Aug 12; 36(8):425-31. PubMed ID: 9726695
[Abstract] [Full Text] [Related]
5. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
McClennen W, Wilson T.
Clin Invest Med; 1998 Jun 12; 21(3):142-50. PubMed ID: 9627768
[Abstract] [Full Text] [Related]
6. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
Middeke M, Richter WO, Schwandt P, Holzgreve H.
Int J Clin Pharmacol Ther; 1997 Jun 12; 35(6):231-4. PubMed ID: 9208337
[Abstract] [Full Text] [Related]
7. Double-blind, parallel, comparative multicentre study of a new combination of diltiazem and hydrochlorothiazide with individual components in patients with mild or moderate hypertension.
Manning G, Joy A, Mathias CJ, McDonald CJ, Millar-Craig MW.
J Hum Hypertens; 1996 Jul 12; 10(7):443-8. PubMed ID: 8880557
[Abstract] [Full Text] [Related]
8. Losartan potassium as initial therapy in patients with severe hypertension.
Dunlay MC, Fitzpatrick V, Chrysant S, Francischetti EA, Goldberg AI, Sweet CS.
J Hum Hypertens; 1995 Nov 12; 9(11):861-7. PubMed ID: 8583463
[Abstract] [Full Text] [Related]
9. Efficacy and tolerability of a combination of enalapril and hydrochlorothiazide in the treatment of hypertension measured manually and with an ambulatory blood pressure monitor.
Weir MR, Lavin PT, Byrnes CA.
Clin Ther; 1993 Nov 12; 15(3):527-38. PubMed ID: 8364944
[Abstract] [Full Text] [Related]
10. [Efficacy and tolerability of the captopril and hydrochlorothiazide combination in the treatment of mild to moderate hypertension. Multicenter study].
Velasco-Cornejo IF, Martin LC, Franco RJ.
Arq Bras Cardiol; 1995 Jun 12; 64(6):571-5. PubMed ID: 8561680
[Abstract] [Full Text] [Related]
11. [Potassium canrenoate and the combination of potassium canrenoate-butizide in the therapy of light to moderate arterial hypertension].
Morabito S, Fabiano M, Puliti M, Palumbo R, Marinelli R, Simonetti BM, Pierucci A.
Clin Ter; 1992 Jul 12; 141(7):23-8. PubMed ID: 1505173
[Abstract] [Full Text] [Related]
12. Double-blind comparison of the efficacy and safety of trandolapril 2 mg and hydrochlorothiazide 25 mg in patients with mild-to-moderate essential hypertension. Investigator Study Group.
Meyer BH, Pauly NC.
J Cardiovasc Pharmacol; 1994 Jul 12; 23 Suppl 4():S77-80. PubMed ID: 7527107
[Abstract] [Full Text] [Related]
13. Long-term open evaluation of amlodipine vs hydrochlorothiazide in patients with essential hypertension.
Adolphe AB, Vlachakis ND, Rofman BA, Brescia D, Zellner SR.
Int J Clin Pharmacol Res; 1993 Jul 12; 13(4):203-10. PubMed ID: 8150546
[Abstract] [Full Text] [Related]
14. Enalapril and enalapril-hydrochlorothiazide in the treatment of essential hypertension. The Enalapril-Hydrochlorothiazide in Essential Hypertension Canadian Working Group.
Clin Ther; 1993 Jul 12; 15(2):364-73. PubMed ID: 8519044
[Abstract] [Full Text] [Related]
15. The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertension. The Eprosartan Multinational Study Group.
Hedner T, Himmelmann A.
J Hypertens; 1999 Jan 12; 17(1):129-36. PubMed ID: 10100104
[Abstract] [Full Text] [Related]
16. Efficacy and tolerability of manidipine hydrochloride in the long-term treatment of mild-moderate hypertension. Manidipine Efficacy in Long-Term Treatment Group.
Fogari R, Zoppi A, Lusardi P, Mugellini A.
Blood Press Suppl; 1996 Jan 12; 5():24-8. PubMed ID: 8973789
[Abstract] [Full Text] [Related]
17. Effects of lisinopril or lisinopril/hydrochlorothiazide compared with adjusting of previous medication and intensifying non-pharmacological treatment in patients with mild to moderate hypertension.
Keinänen-Kiukaanniemi S, Rasmusen M, Pekkarinen T, Pitkäjärvi T, Romo M, Takala J.
Arzneimittelforschung; 1997 Feb 12; 47(2):144-50. PubMed ID: 9079233
[Abstract] [Full Text] [Related]
18. Low-dose bisoprolol/hydrochlorothiazide: an option in first-line, antihypertensive treatment.
Zachariah PK, Messerli FH, Mroczek W.
Clin Ther; 1993 Feb 12; 15(5):779-87. PubMed ID: 8269444
[Abstract] [Full Text] [Related]
19. Global efficacy and tolerability of losartan, an angiotensin II subtype 1-receptor antagonist, in the treatment of hypertension.
Mallion JM, Goldberg AI.
Blood Press Suppl; 1996 Feb 12; 2():82-6. PubMed ID: 8913546
[Abstract] [Full Text] [Related]
20. A double-blind comparison of the efficacy and safety of lacidipine and hydrochlorothiazide in essential hypertension. The Southern Italy Lacidipine Study Group.
Chiariello M.
J Cardiovasc Pharmacol; 1991 Feb 12; 17 Suppl 4():S35-7. PubMed ID: 1726004
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
